Resultado final Documents, reports (3) Ebola virus diversity assessed by sequencing The report will provide an overview of Ebola virus diversity as assessed by sequencing necessary to optimize the diagnostic, treatment and vaccine approaches. Whole infectious profiles The report will provide an overview of the diversity of infectious profiles from available samples. Ethical regulations, security and safety set up for diagnostic and follow-up of patients of the phase 1 (without treatment) Ethical regulations set up to work with the present project for diagnostic and treatment Websites, patent fillings, videos etc. (1) Creation of the specific website of the project Creation of the specific website of the project. Publicaciones Conference proceedings (11) Metagenomic analyses and genomic fingerprint of co-infections of the EBOLA viral disease Autores: W. Valdivia-, D. Sheoran, G. Dubois, S. Tigrett, F. Veas Publicado en: 2015 Editor: Tofo conference on Filovirus, Ebola and Other Filoviruses Development of a specific polyclonal immunoglobulin against Ebola Autores: C. Herbreteau & IF Ebola Publicado en: 2015 Editor: First World Congress on Targeting Ebola Lessons Learned from the Development of an Ebola Immunotherapy Autores: R Metrop, JF Saluzzo, F Veas, C. Herbreteau Publicado en: 2017 Editor: IV International Conference on Mitigation Strategies for Emerging Infectious diseases Specific polyclonal F(ab’)2immunoglobulin fragments; in vitro characterization and in vivo effectiveness in post-exposure treatment against Zaire Ebola virus in mice Autores: M. Denizot, T. Racine, D. Pannetier, A. Pasquier, H. Raoul, JF Saluzzo, G. Kobinger, F. Veas, C. Herbreteau Publicado en: 2017 Editor: The II International Conference CBRNE - Research & Innovation Atypical immune response of EVD Long-term survivors Autores: Y. Eskira A Sobarzo, F Veas L Lobel Publicado en: 2017 Editor: VIII International Conference on Emerging Zoonoses and transboundary Infectious Diseases The preparedness IF-EBOLA toolbox for rapid and efficient mitigation of upcoming outbreaks. A platform model for emerging diseases Autores: F.Veas Publicado en: 2016 Editor: International Conference on Mitigation Strategies for Emerging Infectious diseases Efficiency of innovative preparedness IF-EBOLA technologies: Ultrasensitive diagnostics, horse anti-Ebola virus polyclonal Fabs & metagenomic analyses of Ebola variants and co-infections Autores: F.Veas Publicado en: 2017 Editor: IV International Conference on Mitigation Strategies for Emerging Infectious diseases Ebola virus Genomic and Metagenomic signature Analyses of the 2014-15 West African Outbreak Autores: W. Valdivia, D. Sheoran, & F. Veas Publicado en: Edición 7th Filovirus Conference, 2015 Editor: 7th Filovirus Conference Multi-technological platforms to solve unmet needs for rapid and efficient management of emerging diseases Autores: F.Veas Publicado en: 2015 Editor: XIX International Congress for Tropical Diseases A Universal virus capture method leading to a rapid and ultrasensitive detection of pathogens for early & late post-exposure countermeasures Autores: S Tigrett, L Lobel, F Veas Publicado en: 2017 Editor: VIII International Conference on Emerging Zoonoses and transboundary Infectious diseases RIGEL as a Powerful Computational Architecture for Genomic & Metagenomic Signature Discrimination: Analysis of the 2014-15 West African EBOLA Outbreak” Autores: W. Valdivia, D. Sheoran & F. Veas Publicado en: Edición Gordon Research Conferences, on Biodefense and Bioterrorism meeting, 2015, Página(s) March 8-13, 2015 Editor: Gordon Research Conference Other (1) Resveratrol-Linoleate protects from exacerbated endothelial permeability via a drastic inhibition of the MMP-9 activity Autores: A Shamseddin, C Crauste, E Durand, P Villeneuve, G Dubois, T Pavlickova, Th Durand, J. Vercauteren, and F Veas Publicado en: 2018 Editor: BioScience Reports 2018 Peer reviewed articles (1) Resveratrol formulated with a natural deep eutectic solvent inhibits active matrix metalloprotease-9 in hormetic conditions Autores: Aly Shamseddin, Céline Crauste, Erwann Durand, Pierre Villeneuve, Gregor Dubois, Thierry Durand, Joseph Vercauteren, Francisco Veas Publicado en: European Journal of Lipid Science and Technology, Edición 119/11, 2017, Página(s) 1700171, ISSN 1438-7697 Editor: Wiley - V C H Verlag GmbbH & Co. DOI: 10.1002/ejlt.201700171 Buscando datos de OpenAIRE... Se ha producido un error en la búsqueda de datos de OpenAIRE No hay resultados disponibles
